Abstract
It is hypothesized that novel thiolated chitosan-coated multilayer microparticles (MPs) with enhanced drug loading are more mucoadhesive than uncoated MPs and safe in vivo for vaginal delivery of topical anti-HIV microbicide. Formulation optimization is achieved through a custom experimental design and the alginate (AG) MPs cores are prepared using the spray drying method. The optimal MPs are then coated with the thiolated chitosan (TCS) using a layer-by-layer method. The morphological analysis, in situ drug payload, in vitro drug release profile, and mucoadhesion potential of the MPs are carried out using scanning electron microscopy, solid-state 31P NMR spectroscopy, UV spectroscopy, fluorescence imaging and periodic acid Schiff method, respectively. The cytotoxicity and preclinical safety of MPs are assessed on human vaginal (VK2/E6E7) and endocervical (End1/E6E7) epithelial cell lines and in female C57BL/6 mice, respectively. The results show that the MPs are successfully formulated with an average diameter ranging from 2 to 3 μm with a drug loading of 7–12% w/w. The drug release profile of these MPs primarily follows the Baker-Lonsdale and Korsmeyer-Peppas models. The MPs exhibit high mucoadhesion (20–50 folds) compared to native AGMPs. The multilayer MPs are noncytotoxic. Histological and immunochemical analysis of the mice genital tract shows neither signs of damage nor inflammatory cell infiltrate. These data highlight the potential use of TCS-coated AG-based multilayer MPs templates for the topical vaginal delivery of anti-HIV/AIDS microbicides.
Similar content being viewed by others
References
Poelvoorde N, Verstraelen H, Verhelst R, Saerens B, De Backer E, dos Santos Santiago GL, et al. In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulation. Eur J Pharm Biopharm. 2009;73(2):280–4.
Alukda D, Sturgis T, Youan BB. Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention. J Pharm Sci. 2011;100(8):3345–56.
Agrahari V, Zhang C, Zhang T, Li W, Gounev TK, Oyler NA, et al. Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV/AIDS microbicide in vitro. AAPS J. 2014;16(2):181–93.
Meng J, Sturgis TF, Youan BB. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci. 2011;44(1–2):57–67.
Meng J, Zhang T, Agrahari V, Ezoulin MJ, Youan BB. Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention. Nanomedicine. 2014;9(11):1595–612.
Zhang T, Zhang C, Agrahari V, Murowchick JB, Oyler NA, Youan BB. Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention. Antivir Res. 2013;97(3):334–46.
Bilancetti L, Poncelet D, Loisel C, Mazzitelli S, Nastruzzi C. A statistical approach to optimize the spray drying of starch particles: application to dry powder coating. AAPS PharmSciTech. 2010;11(3):1257–67.
Li X, Anton N, Arpagaus C, Belleteix F, Vandamme TF. Nanoparticles by spray drying using innovative new technology: the Buchi nano spray dryer B-90. J Control Release. 2010;147(2):304–10.
Peltonen L, Valo H, Kolakovic R, Laaksonen T, Hirvonen J. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles. Expert Opin Drug Deliv. 2010;7(6):705–19.
Leitner VM, Walker GF, Bernkop-Schnurch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm. 2003;56(2):207–14.
Meng J, Agrahari V, Ezoulin M, Zhang C, Purohit S, Moltenic A, et al. Tenofovir containing thiolated chitosan core/shell nanofibers: in vitro and in vivo evaluations. Mol Pharmaceutics. 2016. doi:10.1021/acs.molpharmaceut.6b00739.
Li X, Kong X, Shi S, Zheng X, Guo G, Wei Y, et al. Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol. 2008;8:89–100.
Shinde UA, Nagarsenker MS. Characterization of gelatin-sodium alginate complex coacervation system. Indian J Pharm Sci. 2009;71(3):313–7.
D’Souza SS, DeLuca PP. Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech. 2005;6(2):E323–8.
Sassi AB, Isaacs CE, Moncla BJ, Gupta P, Hillier SL, Rohan LC. Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci. 2008;97(8):3123–39.
Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59(2):91–5.
Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263–71.
Han HK, Shin HJ, Ha DH. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci. 2012;46(5):500–7.
Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014;2014(6):655–8.
Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, et al. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother. 2004;48(5):1837–47.
Bei D, Marszalek J, Youan BB. Formulation of dacarbazine-loaded cubosomes—part I: influence of formulation variables. AAPS PharmSciTech. 2009;10(3):1032–9.
Singh SK, Banala VT, Gupta GK, Verma A, Shukla R, Pawar VK, et al. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells. Drug Dev Ind Pharm. 2015;41:1759–68.
zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm. 1998;45(2):149–55.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.
Aho K, Derryberry D, Peterson T. Model selection for ecologists: the worldviews of AIC and BIC. Ecology. 2014;95(3):631–6.
Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206(1):6–14.
Heng PW, Chan LW, Tang ES. Use of swirling airflow to enhance coating performance of bottom spray fluid bed coaters. Int J Pharm. 2006;327(1–2):26–35.
Masters K. Spray-air contact, particle formation and drying. Spray drying in practice. Denmark: SprayDryConsult Intl. ApS; 2002. p. 129–191.
Maury M, Murphy K, Kumar S, Shi L, Lee G. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. Eur J Pharm Biopharm. 2005;59(3):565–73.
Chapter 6. Viscosity. In: Sperling LH, editor. Introduction to physical polymer science. 4th ed 2006. p. 77–87.
Hamdy S, Haddadi A, Ghotbi Z, Hung RW, Lavasanifar A. Part I: targeted particles for cancer immunotherapy. Curr Drug Deliv. 2011;8(3):261–73.
Hung RW, Hamdy S, Haddadi A, Ghotbi Z, Lavasanifar A. Part II: targeted particles for imaging of anticancer immune responses. Curr Drug Deliv. 2011;8(3):274–81.
LeClair DA, Cranston ED, Xing Z, Thompson MR. Optimization of spray drying conditions for yield, particle size and biological activity of thermally stable viral vectors. Pharm Res. 2016;33(11):2763–76.
Kanojia G, Willems GJ, Frijlink HW, Kersten GF, Soema PC, Amorij JP. A design of experiment approach to predict product and process parameters for a spray dried influenza vaccine. Int J Pharm. 2016;511(2):1098–111.
Fang Y, Al-Assaf S, Phillips GO, Nishinari K, Funami T, Williams PA, et al. Multiple steps and critical behaviors of the binding of calcium to alginate. J Phys Chem B. 2007;111(10):2456–62.
Lee WA, He GX, Eisenberg E, Cihlar T, Swaminathan S, Mulato A, et al. Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. Antimicrob Agents Chemother. 2005;49(5):1898–906.
Chantler E, Debruyne E. Factors regulating the changes in cervical mucus in different hormonal states. Adv Exp Med Biol. 1977;89:131–41.
Gipson IK, Ho SB, Spurr-Michaud SJ, Tisdale AS, Zhan Q, Torlakovic E, et al. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod. 1997;56(4):999–1011.
Clift AF. Early studies on the rheology of cervical mucus. Am J Obstet Gynecol. 1979;134(7):829–32.
Godley MJ. Quantitation of vaginal discharge in healthy volunteers. Br J Obstet Gynaecol. 1985;92(7):739–42.
Bogataj M, Vovk T, Kerec M, Dimnik A, Grabnar I, Mrhar A. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. Biol Pharm Bull. 2003;26(5):743–6.
Acknowledgments
The work presented was supported by Award Number R01AI087304 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The authors would like to thank Dr. Vladimir Dusevich (Director, Electron Microscopy Facility, School of Dentistry, University of Missouri-Kansas City, MO) for the electron microscopy.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Otilia M. Koo, Panayiotis P. Constantinides, Lavinia M. Lewis, and Joseph Reo
Jianing Meng and Vivek Agrahari contributed equally to this work.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 114 kb)
Rights and permissions
About this article
Cite this article
Meng, J., Agrahari, V., Ezoulin, M.J. et al. Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery. AAPS J 19, 692–702 (2017). https://doi.org/10.1208/s12248-016-0007-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-016-0007-y